Astrazeneca

FromAstraZeneca ([email protected])
Subject (45)Imfinzi approved in US for limited-stage SCLC
Preheader (121)Imfinzi approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
Typography
Arial
Colors
Text Analysis
Body Words211
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px734 px
X-Spam Score-3.1
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeEvening

Imfinzi approved in US for limited-stage SCLC

Imfinzi approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
Imfinzi approved in US for limited-stage SCLC